⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KPRX News
Kiora Pharmaceuticals, Inc. Common Stock
Catalight Chief Clinical Officer Dr. Doreen Samelson Named Gold Winner in 2025 Merit Awards for Healthcare
prnewswire.com
KPRX
Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds
newsfilecorp.com
KPRX
Kiora Pharmaceuticals Reports Third Quarter 2025 Results; Company Advances Pipeline with Two Actively Enrolling Phase 2 Clinical Trials for Retinal Diseases
newsfilecorp.com
KPRX
Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders
prnewswire.com
KPRX